Why does IRTC lag the market?
Up 17% over five years while the S&P 500 rose 76%.
“The decrease in net loss was primarily driven by our revenue growth and operating leverage achieved through implementation of efficiency initiatives.”
IRTC's Quality Score rose 2 points on Wed, Nov 4, to 8. More shares traded on its up days than on its down days lately (2 chart checks started).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 17% over five years while the S&P 500 rose 76%.
“The decrease in net loss was primarily driven by our revenue growth and operating leverage achieved through implementation of efficiency initiatives.”
| The company | Sales up 26% on the year |
| Latest filing | 8-K, Oct 5 |
ReportReports today, after the close. Every 3 months, a company tells everyone how much it sold and earned. It fell after 3 of its last 4 reports, -2.5% on average. Past reports ›
After its last 4 reports it closed -2.5% on average, higher 1 of 4 times.
Averagefor quality, not price, 6 of 14 chart checks firingWhat the Quality Score means
Well above its recent run. IRTC scores 8 today, against a median of 2 over its last 20 recorded sessions.
IRTC is #33 of 85 by Quality Score.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 33 |
Net income over four quarters: IRTC -$13.9M, INSP $135M, DXCM $1.00B.
Reports Thu Nov 5, after the close (today). Confirmed.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
The figures are not read from the release yet.
“The increase was driven primarily by sustained volume demand across our customer base, reflecting continued strength in our core business and contributions from newer growth channels.”
IRTC's results filing gives no sales by line in a table we read.
No outlook figures read from this release.
“The improvement was primarily driven by our revenue growth and operating leverage achieved through implementation of efficiency initiatives.”
From its results filing (SEC filing · Aug 6)
Sales grew 23% a year over 5 years, fiscal 2020 to 2025.
Its share count grew 2.9% a year over 5 years.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Aug 6, 2026 | +2.7% | -0.2% | -3.9% |
| Apr 30, 2026 | -1.8% | -6.5% | -3.3% |
| Feb 19, 2026 | -2.2% | -5.0% | -11.8% |
Sales grew every year from 2018 to 2025, to $747M. It lost money in each of the eight years.
10 insiders sold $8M across 13 filings in the last 6 months. No open-market buys on record. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: IRTC is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
“The market for remote cardiac monitoring is competitive, characterized by rapid change resulting from technological advances, scientific discoveries, and other market activities of industry participants.”
IRTC scores 8 today, which Breakaway calls Average. It is #33 of 85 in Medical Devices by Quality Score, with 6 of 14 chart checks firing. Up 17% over five years while the S&P 500 rose 76%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
IRTC scores 8 today, which Breakaway calls Average (6 to 10). That is #33 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind IRTC's 8.
10 insiders sold $8M across 13 filings in the last 6 months. No open-market buys on record. The newest is Daniel G. Wilson, Chief Financial Officer, who sold $94K on Sep 2. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.